Title: Association between albumin-to-globulin ratio and the risk of overall survival in advanced non-small cell lung cancer patients with anlotinib treatment: a retrospective cohort study
Venue: BMC Pulmonary Medicine
Year: 2023
Abstract: None
CMU authors: Yiming Yang
Other authors: Jinzhan Chen, Cong-jun Xie, Shuwen Yang, Jin-xiang Huang, Feiyang Ye, Zhenyang Lin, L. Tong, Jiaxin Liu
tldr: AGR level is an independent protective factor for OS in advanced NSCLC patients who received anlotinib therapy, and was positively associated with OS when AGR was larger than 1.24, for every 1 unit increase in AGR, the risk of death lowered approximately by 80%.
